阿片类药物市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00004770
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 209
Buy Now

Opioids Market Size, Share, and Growth Overview by 2031

Buy Now

 

预计到 2031 年,阿片类药物市场规模将从 2023 年的 129.3 亿美元增至 150.3 亿美元。预计 2023-2031 年市场复合 年增长率为 1.9%。推动市场增长的关键因素包括全球慢性疼痛发病率激增和老年人口增加。

阿片类药物市场分析

心血管疾病、癌症、肌肉骨骼疾病和神经血管疾病等慢性疾病会降低免疫力,严重影响人体健康。此外,许多患有这些疾病的患者会经历慢性疼痛。上述疾病在成年人和老年人群中最常见。然而,儿童中这些疾病的病例也明显增加。慢性疼痛在运动员、运动员和过去受过伤的人中也很常见。2021 年,美国疾病控制和预防中心 (CDC) 的国家伤害预防和控制中心报告称,慢性疼痛影响了美国约 20% 的成年人。阿片类药物在疼痛管理方面的优势推动了它们在慢性病管理程序中的需求。

阿片类药物市场概况

慢性疼痛发病率的飙升和老年人口的增加是阿片类药物市场扩张的主要因素。根据美国国会研究服务处的数据,美国人可能会以牺牲更全面的疼痛治疗为代价获得更多的阿片类药物。阿片类药物处方量的增加可以归因于保险报销计划,这些计划鼓励人们使用阿片类药物而不是替代性疼痛治疗,成本结构鼓励更有效的护理,以及将患者满意度与有效疼痛管理相结合的评估。因此,由于阿片类药物在疼痛管理方面的优势,慢性病患者的需求正在上升。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

阿片类药物市场:

Opioids Market: Strategic Insights

Opioids Market

  • CAGR (2023 - 2031)
    1.9%
  • Market Size 2023
    US$ 12.93 Billion
  • Market Size 2031
    US$ 15.03 Billion

Market Dynamics

GROWTH DRIVERS
  • 老年人口不断增加
FUTURE TRENDS
  • 政府加大力度开发药物,预防和治疗阿片类药物过量使用和滥用
OPPORTUNITIES
  • 市场参与者的战略举措

Key Players

  • Purdue Pharma LP
  • Endo International plc
  • Mallinckrodt Plc
  • Collegium Pharmaceutical Inc
  • Neuraxpharm Pharmaceuticals SL
  • Hikma Pharmaceuticals Plc
  • Mayne Pharma Group LtD
  • Rusan Pharma Ltd
  • Trevena Inc
  • Teva Pharmaceutical Industries Ltd

Regional Overview

  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

产品(速释短效阿片类药物、缓释长效阿片类药物)
    应用(疼痛管理、麻醉、止泻、止咳、戒毒、其他)
      给药途径(口服、注射、透皮贴剂)
        分销渠道(医院药房、零售药房)

          阿片类药物市场

          • 复合年增长率(2023 - 2031)
            1.9%
          • 2023 年市场规模
            129.3 亿美元
          • 2031年市场规模
            150.3亿美元

          市场动态

          增长动力
          • 老年人口不断增加
          未来的趋势
          • 政府加大力度开发预防和治疗阿片类药物过量使用和滥用的药物
          机会
          • 市场参与者的战略举措

          关键人物;主力;重要一员

          • 普渡制药公司
          • 远藤国际公司
          • 马林克罗德股份有限公司
          • Collegium制药公司
          • Neuraxpharm 制药公司
          • Hikma 制药公司
          • 梅恩制药集团有限公司
          • 鲁桑制药有限公司
          • 特雷维纳公司
          • 梯瓦制药工业有限公司

          区域概况

          • 北美
          • 欧洲
          • 亚太
          • 南美洲和中美洲
          • 中东和非洲

          市场细分

          产品
          • 速释短效阿片类药物
          • 缓释长效阿片类药物
          应用
          • 疼痛管理
          • 麻醉
          • 抑制腹泻
          • 止咳
          • 戒除毒瘾
          • 其他的
          给药途径
          • 口服
          • 注射剂
          • 透皮贴剂
          分销渠道
          • 医院药房
          • 零售药店
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

          阿片类药物市场驱动因素和机遇

          老年人口增加有利于阿片类药物市场的发展

          大多数老年人患有慢性疼痛,导致其日常活动能力下降。老年人普遍患有骨关节疾病、关节炎、癌症和其他引起疼痛的慢性疾病。根据世界卫生组织 (WHO) 2018 年 2 月的数据,到 2050 年,老年人口预计将增长 22%,而 2015 年这一数字为 12%。数据还表明,中低收入国家将占这一增长的近 80%。美国、加拿大、英国、法国、德国和日本等发达国家以及中国、印度和韩国等发展中国家的老年人口也在显著增长。因此,老年人口的增加是全球阿片类药物市场增长的主要驱动力。

          市场参与者的战略举措——阿片类药物市场的定制机会

          阿片类药物市场参与者投资研发活动,以确保开发有效的产品。2023 年 5 月,Indivior PLC 获得美国食品药品监督管理局 (FDA) 批准,可使用 OPVEE(纳美芬)鼻喷雾剂紧急使用,用于治疗成人和 12 岁及以上的儿科患者中因合成或天然阿片类药物引起的疑似或已知阿片类药物过量,其特征是中枢神经系统和/或呼吸抑制。此外,2021 年 12 月,山德士宣布在美国推出其仿制药 Narcan(盐酸纳洛酮)鼻喷雾剂 4mg;该产品用于逆转阿片类药物过量。美国个人可以通过零售药店和医院等机构立即获得 Narcan。最后,2023 年 8 月,Emergent BioSolutions 推出了非处方 NARCAN 鼻喷雾剂,让每个人都能帮助挽救因阿片类药物过量而导致的紧急情况的生命。

          因此,战略举措可能会在未来几年为阿片类药物市场提供增长机会。

          阿片类药物市场报告细分分析

          有助于得出阿片类药物市场分析的关键部分是类型、原因、疾病类型、类别和最终用户。

          • 根据类型,阿片类药物市场分为速释短效阿片类药物和缓释长效阿片类药物。速释短效阿片类药物在 2023 年占据了较大的市场份额。预计该细分市场在 2023-2031 年期间的复合年增长率将更高。
          • 根据应用,市场分为疼痛管理、麻醉、止泻、止咳、戒毒等。疼痛管理领域在 2023 年占据了最大的市场份额。
          • 就给药途径而言,市场分为静脉注射、口服和贴剂。口服药物在 2023 年占据了最大的市场份额。
          • 根据最终用户,市场分为医院药房和临床药房。2023 年,医院药房部分占阿片类药物市场的较大份额。

          阿片类药物市场份额分析(按地区划分)

          阿片类药物市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

          2023 年,北美占据了阿片类药物市场的主导地位。阿片类药物过量用药病例激增,影响了阿片类药物市场的增长。根据世界卫生组织 (WHO) 关于阿片类药物过量的统计数据,2019 年美国因药物过量死亡人数为 70,630 人。美国疾病控制与预防中心还估计,1999-2021 年期间,美国约有 280,000 人死于处方阿片类药物过量。全球市场参与者的存在是另一个值得注意的因素,促使北美在全球阿片类药物市场占据主导地位。预计亚太地区将在未来几年创下市场最高复合年增长率。

          阿片类药物市场报告范围

          报告属性细节
          2023 年的市场规模129.3亿美元
          2031 年市场规模150.3亿美元
          全球复合年增长率(2023 - 2031)1.9%
          历史数据2021-2022
          预测期2024-2031
          涵盖的领域按产品
          • 速释短效阿片类药物
          • 缓释长效阿片类药物
          按应用
          • 疼痛管理
          • 麻醉
          • 抑制腹泻
          • 止咳
          • 戒除毒瘾
          • 其他的
          按给药途径
          • 口服
          • 注射剂
          • 透皮贴剂
          按分销渠道
          • 医院药房
          • 零售药店
          覆盖地区和国家北美
          • 我们
          • 加拿大
          • 墨西哥
          欧洲
          • 英国
          • 德国
          • 法国
          • 俄罗斯
          • 意大利
          • 欧洲其他地区
          亚太
          • 中国
          • 印度
          • 日本
          • 澳大利亚
          • 亚太其他地区
          南美洲和中美洲
          • 巴西
          • 阿根廷
          • 南美洲和中美洲其他地区
          中东和非洲
          • 南非
          • 沙特阿拉伯
          • 阿联酋
          • 中东和非洲其他地区
          市场领导者和主要公司简介
          • 普渡制药公司
          • 远藤国际公司
          • 马林克罗德股份有限公司
          • Collegium制药公司
          • Neuraxpharm 制药公司
          • Hikma 制药公司
          • 梅恩制药集团有限公司
          • 鲁桑制药有限公司
          • 特雷维纳公司
          • 梯瓦制药工业有限公司
          • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

          阿片类药物市场新闻和最新发展

          通过收集主要和次要研究后的定性和定量数据来评估阿片类药物市场,其中包括重要的公司出版物、协会数据和数据库。以下是阿片类药物市场的发展和战略列表:

          • 2023 年 3 月,Trevena, Inc. 宣布其在中国的合作伙伴江苏恩华制药有限公司已获得国家药品监督管理局对 OLINVYK 的正式批准。该药物已被批准用于成人治疗严重到需要静脉注射阿片类镇痛药且对替代疗法无效的急性疼痛。(来源:Trevena, Inc.,新闻稿,2023 年)
          • 2023 年 1 月,Neuraxpharm 宣布成立 Neuraxpharm Belgium,覆盖比利时和卢森堡,完成其在比荷卢三国的业务,并继续其在欧洲的扩张之路。(来源:Neuraxpharm,新闻稿,2023 年)
          • 2023 年 2 月,Neuraxpharm 宣布从赛诺菲收购了两个成熟的中枢神经系统 (CNS) 疾病以及疼痛和血管疾病产品组合。Neuraxpharm 收购的成熟产品包括 15 种针对中枢神经系统疾病的产品和 2 种针对疼痛和血管疾病的产品。(来源:Neuraxpharm,新闻稿,2023 年)

          阿片类药物市场报告覆盖范围和交付成果

          “阿片类药物市场规模和预测(2023-2031)”报告对以下领域进行了详细的市场分析:

          • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
          • 市场动态,如驱动因素、限制因素和关键机遇
          • 未来主要趋势
          • 详细的 PEST 和 SWOT 分析
          • 全球和区域市场分析涵盖主要市场趋势、主要参与者、法规和最新的市场发展。
          • 行业格局和竞争分析,包括市场集中度、热图分析、知名参与者和最新发展。
          • 详细的公司简介

          Opioids Market Report Scope

          Report Attribute Details
          Market size in US$ 12.93 Billion
          Market Size by US$ 15.03 Billion
          Global CAGR 1.9%
          Historical Data 2021-2022
          Forecast period 2024-2031
          Segments Covered By 产品(速释短效阿片类药物、缓释长效阿片类药物)
          By 应用(疼痛管理、麻醉、止泻、止咳、戒毒、其他)
          By 给药途径(口服、注射、透皮贴剂)
          By 分销渠道(医院药房、零售药房)
          Regions and Countries Covered 北美(美国、加拿大、墨西哥)
          • 北美(美国、加拿大、墨西哥)
          欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
          亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
          南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
          中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
          Market leaders and key company profiles
        • Purdue Pharma LP
        • Endo International plc
        • Mallinckrodt Plc
        • Collegium Pharmaceutical Inc
        • Neuraxpharm Pharmaceuticals SL
        • Hikma Pharmaceuticals Plc
        • Mayne Pharma Group LtD
        • Rusan Pharma Ltd
        • Trevena Inc
        • Teva Pharmaceutical Industries Ltd
        • Report Coverage
          Report Coverage

          Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

          Segment Covered
          Segment Covered

          This text is related
          to segments covered.

          Regional Scope
          Regional Scope

          North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

          Country Scope
          Country Scope

          This text is related
          to country scope.

          Frequently Asked Questions


          Which application segment dominates the opioids market?

          The opioids market, by application, is segmented into pain management, anesthesia, diarrhea suppression, cough suppression, de-addiction, and others. The pain management held the largest share of the market in 2023. The de-addiction segment is anticipated to register the highest CAGR of 2.4% during the forecast period.

          What was the estimated opioids market size in 2022?

          The opioids market was valued at US$ 12.93 billion in 2023.

          What are the growth estimates for the opioids market till 2031?

          The opioids market is expected to be valued at US$ 15.03 million in 2031.

          Which product type segment dominates the opioids market?

          The opioids market, by product, is segmented into immediate-release short-acting opioids and extended-release long-acting opioids. The immediate release short acting opioid segment held a larger share of the market in 2023. It is further anticipated to register a higher CAGR of 2.0% in the market during the forecast period.

          What factors drive the opioids market?

          Surging chronic pain incidences and increasing geriatric population are the major driving factor promoting the growth of the market. However, increasing drug abuse hinders the market opioid marjet growth.

          Who are the major players in the opioids market?

          The opioids market majorly consists of the players, including Purdue Pharma LP, Endo International plc, Mallinckrodt Plc, Collegium Pharmaceutical Inc, Neuraxpharm Pharmaceuticals SL, Hikma Pharmaceuticals Plc, Mayne Pharma Group Ltd, Rusan Pharma Ltd, Trevena Inc, Teva Pharmaceutical Industries Ltd

          What is Opioids?

          Opioids are the broad group of medicine majorly used for relieving the pain. These medicines are highly effective but can also leads to an addiction. Opioid acts by working on brain receptors and thus provide the varieties of effect including the pain relief. Opioid includes heroin, morphine, codeine, fentanyl, methadone, tramadol, and other similar substances.

          The List of Companies - Opioids Market

          1. Purdue Pharma LP
          2. Endo International plc
          3. Mallinckrodt Plc
          4. Collegium Pharmaceutical Inc
          5. Neuraxpharm Pharmaceuticals SL
          6. Hikma Pharmaceuticals Plc
          7. Mayne Pharma Group Ltd
          8. Rusan Pharma Ltd
          9. Trevena Inc
          10. Teva Pharmaceutical Industries Ltd

          The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

          1. Data Collection and Secondary Research:

          As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

          Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

          1. Primary Research:

          The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

          For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

          A typical research interview fulfils the following functions:

          • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
          • Validates and strengthens in-house secondary research findings
          • Develops the analysis team’s expertise and market understanding

          Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

          • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
          • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

          Below is the breakup of our primary respondents by company, designation, and region:

          Research Methodology

          Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

          1. Data Analysis:

          Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

          • Macro-Economic Factor Analysis:

          We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

          • Country Level Data:

          Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

          • Company Profile:

          The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

          • Developing Base Number:

          Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

          1. Data Triangulation and Final Review:

          The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

          We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

          We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

          Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

          Trends and growth analysis reports related to Pharmaceuticals : READ MORE..